Detalhe da pesquisa
1.
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).
J Neurol Neurosurg Psychiatry
; 95(5): 392-400, 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37963723
2.
Does aerobic training alleviate fatigue and improve societal participation in patients with multiple sclerosis? A randomized controlled trial.
Mult Scler
; 23(11): 1517-1526, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28528566
3.
Persistence and adherence in multiple sclerosis patients starting glatiramer acetate treatment: assessment of relationship with care received from multiple disciplines.
Patient Prefer Adherence
; 10: 909-17, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27307711